Our study provides new insights by showing that MST1 deficiency leads to impaired cholesterol homeostasis, contributing to heightened inflammatory responses and fibrogenesis, which are hallmarks of NASH progression. Here, MST1 is linked to metabolic dysfunction-associated steatohepatitis.